The oncolytic virus therapy market is rapidly evolving as a forefront innovation within biopharmaceutical oncology, harnessing genetically modified viruses to selectively target and destroy cancer cells. Significant advances in clinical outcomes and technological development underscore its expanding market scope and dynamic business growth potential. https://www.coherentmarketinsights.com/market-insight/oncolytic-virus-therapy-market-5916